2421 - 2430 of 6467 Results
Title
Year
- miEAA 2.0: integrating multi-species microRNA enrichment analysis and workflow management systems2020OPENTitle: miEAA 2.0: integrating multi-species microRNA enrichment analysis and workflow management systemsJournal Name: Nucleic Acids ResearchPublisher: Oxford University Press (OUP)Vol: 48Issue #: W1Start Page: W521End Page: W528Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1093/nar/gkaa309Best OA location URL: https://academic.oup.com/nar/article-pdf/48/W1/W521/33433413/gkaa309.pdfCitation Count: 198
-
OPENTitle: miRSwitch: detecting microRNA arm shift and switch eventsJournal Name: Nucleic Acids ResearchPublisher: Oxford University Press (OUP)Vol: 48Issue #: W1Start Page: W268End Page: W274Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/nar/gkaa323Best OA location URL: https://academic.oup.com/nar/article-pdf/48/W1/W268/33432877/gkaa323.pdfCitation Count: 32
-
OPENTitle: Mitochondrial tRNA methylation in Alzheimer’s disease and progressive supranuclear palsyJournal Name: BMC Medical GenomicsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page: 71End Page: 71Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12920-020-0727-9Best OA location URL: https://bmcmedgenomics.biomedcentral.com/track/pdf/10.1186/s12920-020-0727-9Citation Count: 18
- Dopamine Buffering Capacity Imaging: A Pharmacodynamic fMRI Method for Staging Parkinson Disease2020OPENTitle: Dopamine Buffering Capacity Imaging: A Pharmacodynamic fMRI Method for Staging Parkinson DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 11Issue #:Start Page: 370End Page: 370Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2020.00370Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2020.00370/pdfCitation Count: 13
-
OPENTitle: Sleep Spindles and Fragmented Sleep as Prodromal Markers in a Preclinical Model of LRRK2-G2019S Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 11Issue #:Start Page: 324End Page: 324Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2020.00324Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2020.00324/pdfCitation Count: 9
-
OPENTitle: Non-motor Clinical and Biomarker Predictors Enable High Cross-Validated Accuracy Detection of Early PD but Lesser Cross-Validated Accuracy Detection of Scans Without Evidence of Dopaminergic DeficitJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 11Issue #:Start Page: 364End Page: 364Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2020.00364Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2020.00364/pdfCitation Count: 11
-
OPENTitle: Quantitative Measurements of LRRK2 in Human Cerebrospinal Fluid Demonstrates Increased Levels in G2019S PatientsJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page: 526End Page: 526Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00526Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2020.00526/pdfCitation Count: 34
-
OPENTitle: Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s diseaseJournal Name: Frontiers in ImmunologyPublisher: Frontiers Media SAVol: 15Issue #:Start Page: 1349030End Page: 1349030Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fimmu.2024.1349030Best OA location URL: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1349030/pdfCitation Count: 15
-
OPENTitle: Atypical antipsychotic use and mortality risk in Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 103Issue #:Start Page: 17End Page: 22Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.08.013Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11000674Citation Count: 8
-
OPENTitle: CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson’s disease: a study in LRRK2 mutation carriersJournal Name: Translational NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page: 15End Page: 15Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40035-020-00192-4Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/77562Citation Count: 62